Concurrence Launches Superintelligent Care Research Program to Forecast Patient Health Trajectories Using Digital Twins
Today, we’re introducing the next chapter of Concurrence and the world’s greatest leap toward Superintelligent Care. When I was 13 I lost my mom to cancer that should’ve been caught earlier. We’re building a system that sees every patient’s future in time to change the outcome
Context
Unifying fragmented electronic health records into longitudinal patient digital twins that compound clinical learnings across millions of encounters aims to shift healthcare AI from administrative scribing to early predictive intervention.
Originally founded as clinical AI deployment platform Amigo, the New York based company rebranded as Concurrence in September 2026 and partnered with Databricks to build longitudinal Health World Models across Epic, Oracle Health, and Athenahealth electronic health record systems. Concurrence's clinical AI agents have supported more than 10 million patient interactions across intake, medication management, and clinical decision support under HIPAA and SOC 2 Type II compliance.
Deep dive
On October 27, Concurrence founder and CEO Ali Khokhar introduced the company's next phase, centered on a research and platform initiative called Superintelligent Care. Sharing that he lost his mother at age 13 to a cancer that should have been detected earlier, Khokhar described how traditional hospital records capture isolated clinical billing events while leaving long diagnostic gaps between visits, causing doctors to miss subtle early warning patterns across a patient's history.
Concurrence's Superintelligent Care architecture is built around a unified data foundation called the Health World Model, which constructs a continuously updated longitudinal digital twin of each patient from fragmented electronic health records and live care interactions. The program is structured around four operational goals: forecasting probable future health trajectories before symptoms escalate, identifying targeted clinical actions that can alter those trajectories, staying engaged with patients between office visits through governed AI agents, and transferring empirical learnings from each patient outcome to every subsequent patient on a similar path.
To execute this roadmap, Concurrence organized its research division around four technical pillars: context, governance, outcomes, and learning. Drawing on data from more than 10 million patient interactions already supported by Concurrence agents within established clinical protocols, the team's immediate research priorities focus on privacy preserving patient archetypes, de biasing observational medical records, calibrating uncertainty before agents take autonomous clinical actions, and publishing retrospective cohort studies such as digital engagement phenotyping in GLP 1 weight loss programs.
What to expect next
Because Concurrence already integrates natively with major electronic health record platforms including Epic, Oracle Health, and Athenahealth and builds its Health World Models on Databricks Delta Lake and Unity Catalog, health systems can test trajectory forecasting on top of their existing clinical data stacks. Watch for peer reviewed validation studies measuring whether Concurrence's digital twin predictions measurably improve early disease detection and chronic care adherence in prospective hospital trials.